| Q33225366 | 3D-chiral atom, atom-type, and total non-stochastic and stochastic molecular linear indices and their applications to central chirality codification |
| Q92705241 | Adaptation of the Systematic Review Framework to the Assessment of Toxicological Test Methods: Challenges and Lessons Learned with the Zebrafish Embryotoxicity Test |
| Q33977465 | Clinical pharmacokinetics of thalidomide |
| Q35036726 | Dimethoxyethyl phthalate: embryopathy, teratogenicity, fetal metabolism and the role of zinc in the rat |
| Q89187336 | Early specification and development of rabbit neural crest cells |
| Q30454939 | Eyeblink conditioning in the developing rabbit |
| Q36091315 | Goiter with vascular anomalies in a litter of Polish Lowland sheepdogs |
| Q34406463 | Identification of thalidomide-specific transcriptomics and proteomics signatures during differentiation of human embryonic stem cells |
| Q90382554 | In Vitro Microscale Models for Embryogenesis |
| Q30415540 | Prenatal antidepressant exposure: clinical and preclinical findings |
| Q89586015 | Systems Modeling of Developmental Vascular Toxicity |
| Q36624697 | Teratogenic and embryocidal effects of Zidovudine (AZT) in sprague-dawley rats |
| Q69416120 | Teratologic studies on the Himalayan rabbit: new aspects of thalidomide-induced teratogenesis |
| Q73128904 | Thalidomide analogue CC1069 inhibits development of rat adjuvant arthritis |
| Q57811694 | Thalidomide and neurotrophism |
| Q35353384 | Thalidomide teratogenesis: evidence for a toxic arene oxide metabolite |
| Q36606177 | Thalidomide-induced limb abnormalities in a humanized CYP3A mouse model |